Also seen on reports as: Serum Insulin (Fasting), Insulin
What is Fasting Insulin?
Fasting Insulin measures the level of insulin circulating in the blood after the body has been without food for 8–12 hours. Insulin is the hormone the pancreas releases to help cells take up glucose from the blood; the fasting level shows the body's baseline insulin output.
Fasting insulin is usually most informative when interpreted alongside fasting glucose. The two together are used to calculate an insulin-resistance score called HOMA-IR (Homeostasis Model Assessment of Insulin Resistance), which estimates how hard the pancreas is having to work to keep fasting sugar in range.
The test is run on a small blood sample drawn from a vein. Reference ranges and units vary noticeably between Indian labs — most report in µIU/mL (microunits per millilitre), but some use pmol/L or mIU/L. Always interpret the value against the range printed on the same report.
Why doctors order it
Fasting insulin is most commonly ordered when a doctor suspects insulin resistance — for example, in someone with central (abdominal) obesity, polycystic ovary syndrome (PCOS), acanthosis nigricans (dark, velvety skin patches around the neck or armpits), fatty liver on ultrasound, or a strong family history of type-2 diabetes — even when fasting glucose is still in the normal range.
In Indian practice, where 'lean' type-2 diabetes and insulin resistance at normal body weight are relatively common, fasting insulin can pick up early signals that fasting glucose alone might miss. It is sometimes ordered as part of a metabolic-syndrome work-up alongside lipid profile, fasting glucose, HbA1c, and liver enzymes.
It is also used in PCOS management, in evaluating unexplained weight gain or treatment-resistant weight loss, and occasionally in suspected reactive hypoglycaemia. Fasting insulin is not used as a primary diabetes screening test — fasting glucose and HbA1c remain the front-line tests for that.
What the result means
There is no single universally agreed cut-off for what counts as 'high' or 'low' fasting insulin — different labs and different clinical groups use different thresholds. Most NABL-accredited Indian labs report a non-diabetic adult reference range that sits somewhere between 2.6 and 24.9 µIU/mL, though the exact endpoints differ.
Doctors often look at fasting insulin together with fasting glucose using HOMA-IR. A higher HOMA-IR value suggests the pancreas is having to release more insulin than usual to keep fasting sugar in range — a sign of insulin resistance. HOMA-IR cut-offs themselves are not uniform; some Indian groups use ≥2.5 as the working threshold for insulin resistance, others use ≥2.7 or higher.
A high fasting insulin in the presence of normal fasting glucose typically points to insulin resistance — the pancreas is still able to compensate, but is working harder. A low fasting insulin with high fasting glucose can point to a more advanced state where insulin production itself is reduced. Either pattern is read by the doctor in the context of the rest of the clinical picture.
Reference range
Values typically reported in µIU/mL. Exact reference range varies between Indian labs — always interpret against the range on the same report.
- Typical adult reference range (non-diabetic)
- Roughly 2.6 – 24.9 µIU/mL (lab-dependent)
- HOMA-IR — insulin sensitivity (calculated, not measured)
- Lower values suggest better sensitivity; higher values (often ≥2.5–2.7) suggest insulin resistance
- Very low fasting insulin
- Suggests reduced insulin production — interpret with fasting glucose
Fasting insulin reference ranges are NOT standardised across labs. Two readings from different labs cannot be directly compared. Doctors interpret the value alongside fasting glucose, HOMA-IR, and the clinical picture.
Common factors that affect the result
Like all fasting tests, the result is affected by fasting duration — typically 8–12 hours is required. Recent meals (especially carbohydrate-rich ones), recent intense exercise, acute illness, and acute stress can all distort fasting insulin readings.
Several medications can raise or lower fasting insulin. Steroids, oral contraceptives (some formulations), some psychiatric medications, and beta-blockers can raise insulin levels. Metformin and other insulin-sensitising medications can lower them. Patients are usually asked to mention all current medications and supplements before the test.
Pregnancy substantially changes baseline insulin levels — pregnancy reference ranges are different and obstetric guidance applies. Acute infections, sleep deprivation, and irregular meal patterns in the days before the test can also shift the value.
When to talk to your doctor
- Your fasting insulin is high while your fasting glucose is still in the normal range — this is a common pattern of early insulin resistance and is worth discussing.
- You have PCOS, fatty liver, central obesity, or acanthosis nigricans — fasting insulin findings should be interpreted in that wider context.
- Your HOMA-IR is calculated and falls above the lab's cut-off — it does not by itself diagnose diabetes, but it does signal metabolic risk.
- Your fasting insulin is unexpectedly low alongside a high fasting glucose — this combination needs medical interpretation and is not necessarily a typical type-2 diabetes pattern.
- You are starting, stopping, or changing a medication known to affect insulin levels — discuss whether the timing of the test should change.
Related tests
Sources
- RSSDI Clinical Practice Recommendations — Research Society for the Study of Diabetes in India
- Indian Consensus on PCOS (FOGSI) — Federation of Obstetric and Gynaecological Societies of India
- ICMR Guidelines for Management of Type 2 Diabetes — Indian Council of Medical Research
- HOMA-IR methodology — original publication — Matthews DR et al., Diabetologia (1985)
- Insulin Assay Standardisation — International Federation of Clinical Chemistry (IFCC)
See our medical disclaimer for what this content is and is not.